类风湿关节炎中对翻译后修饰蛋白的免疫反应:其独特性何在?
本综述总结了近年来关于抗瓜氨酸化蛋白免疫反应生物学及其临床关联的新见解,包括ACPA可变域糖基化、ACPA对多种翻译后修饰蛋白的多反应性以及黏膜部位在ACPA反应发生中的贡献作用,并将这些发现与其他具有疾病特异性自身抗体的自身免疫病中的新概念进行对照。
要点
- ACPA可变域糖基化、对多种翻译后修饰蛋白的多反应性及黏膜部位参与是抗瓜氨酸化蛋白反应的新见解。
- 抗瓜氨酸化蛋白免疫反应参与RA发病机制,深入了解其免疫通路有助于理解RA及其他自身抗体阳性自身免疫病。
- 遗传与环境风险因素及微生物组对自身抗体形成的可能贡献共同勾勒出RA进展中B细胞对修饰抗原反应更清晰的图景。
核心结论
- 抗瓜氨酸化蛋白免疫反应参与RA发病机制,近期关于ACPA生物学及临床关联的新见解与其他自身免疫病中的新概念相互印证,使RA进展中B细胞对修饰抗原的反应图景逐渐清晰。
研究设计与样本
- 综述,总结近年来关于抗瓜氨酸化蛋白反应生物学及其临床关联的新见解,并与其他以疾病特异性自身抗体为特征的人类自身免疫病中的新概念进行对照。
主要发现
- 鉴定出ACPA可变域中的糖基。
- 认识到ACPA对蛋白质上其他翻译后修饰具有多反应性。
- 对黏膜部位在ACPA反应发生中的贡献作用有了新认识。
- 结合对遗传与环境风险因素的更新理解以及微生物组如何促进抗体形成的新视角,这些进展共同使RA进展中B细胞对修饰抗原的反应图景逐渐清晰。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rheumatoid arthritis (RA) exhibits common characteristics with numerous other autoimmune diseases, including the presence of susceptibility genes and the presence of disease-specific autoantibodies. Anti-citrullinated protein antibodies (ACPA) are the hallmarking autoantibodies in RA and the anti-citrullinated protein immune response has been implicated in disease pathogenesis. Insight into the immunological pathways leading to anti-citrullinated protein immunity will not only aid understanding of RA pathogenesis, but may also contribute to elucidation of similar mechanisms in other autoantibody-positive autoimmune diseases. Similarly, lessons learnt in other human autoimmune diseases might be relevant to understand potential drivers of RA. In this review, we will summarise several novel insights into the biology of the anti-citrullinated protein response and their clinical associations that have been obtained in recent years. These insights include the identification of glycans in the variable domain of ACPA, the realisation that ACPA are polyreactive towards other post-translational modifications on proteins, as well as new awareness of the contributing role of mucosal sites to the development of the ACPA response. These findings will be mirrored to emerging concepts obtained in other human (autoimmune) disease characterised by disease-specific autoantibodies. Together with an updated understanding of genetic and environmental risk factors and fresh perspectives on how the microbiome could contribute to antibody formation, these advancements coalesce to a progressively clearer picture of the B cell reaction to modified antigens in the progression of RA.
引用
- van der Woude D, Toes REM. Immune response to post-translationally modified proteins in rheumatoid arthritis: what makes it special? Ann Rheum Dis. 2024. PMID: 38378236. doi:10.1136/ard-2023-224103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。